Â¥
8.25
Aug 23
New Key Statistics Module, Z-Score and F-Score
SZSE:002581 Key Ratios
Market Cap ¥ M | 5,442.82 |
Enterprise Value ¥ M | 5,140.09 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.66 |
Price/Sales | 12.40 |
Price/Free Cash Flow | 515.65 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 437.00 |
EPS (TTM) ¥ | -0.51 |
Beneish M-Score | -2.7 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -1,097.80 |
EV-to-EBIT | -17.67 |
EV-to-EBITDA | -17.67 |
PEG | -- |
Shares Outstanding M | 659.74 |
Net Margin (%) | -77.32 |
Operating Margin % | -37.39 |
Pre-tax Margin (%) | -72.75 |
Quick Ratio | 5.58 |
Current Ratio | 6.70 |
ROA % (ttm) | -13.12 |
ROE % (ttm) | -15.12 |
ROIC % (ttm) | -7.37 |
Dividend Yield % | -- |
Altman Z-Score | 35.97 |
SZSE:002581 Number of Guru Trades
SZSE:002581 Volume of Guru Trades
Gurus Latest Trades with SZSE:002581
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002581 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shandong Sinobioway Biomedicine Co Ltd Insider Transactions
No Available Data